Losing His Sight, a Scientist Sees an End to a Deadly Disease
In a Nautilus profile, Dr. William Jacobs, Jr., discusses the key breakthroughs in his tuberculosis research and how losing his vision impacted his career path.
Bill Jacobs, the TB terminator
The American Association for the Advancement of Science features Dr. William Jacobs, Jr., dubbed the “TB Terminator,” on its “Member Spotlight” blog. The profile highlights Dr. Jacobs’ pioneering use of molecular genetics to control TB, his drive to discover a new vaccine and his work to encourage student interest – from high school to the master’s level – in science.
TUBERCULOSIS TREATMENT AND MYCOBACTERIAL GENETICS WITH BILL JACOBS
Host Julie Wolf interviews Bill Jacobs on ASM's Meet the Microbiologist podcast. He talks about developing mycobacterial genetic tools and using them to discover ways to shorten TB treatment. He also talks about the SEA-PHAGES program that allows high-school students to participate in phage discovery.
X-Vax Technology Raises $56 Million in Upsized Series A Financing to Advance Lead Herpes Vaccine Program
-A new approach to beating herpes by inducing antibodies that mediate the killing of infected cells
-Participants include Johnson & Johnson Innovation - JJDC, Inc. (JJDC); Adjuvant Capital, an impact investment fund supported by the Bill & Melinda Gates Foundation as an anchor investor; Serum Institute of India; Alexandria Venture Investments; Founders Fund.